Vasso Apostolopoulos Selected Research

MBP-8298

12/2018

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82⁻98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasso Apostolopoulos Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 05/2002
29	Multiple Sclerosis 03/2022 - 01/2002
16	COVID-19 11/2022 - 01/2020
11	Inflammation (Inflammations) 01/2022 - 01/2002
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 01/2002
7	Breast Neoplasms (Breast Cancer) 11/2017 - 02/2005
7	Adenocarcinoma 01/2017 - 01/2006
6	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 01/2009
5	Infections 11/2022 - 01/2020
5	Communicable Diseases (Infectious Diseases) 01/2022 - 09/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 12/2017
4	Pain (Aches) 08/2021 - 01/2013
4	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 01/2002
4	Hypersensitivity (Allergy) 02/2021 - 02/2006
3	Virus Diseases (Viral Diseases) 11/2022 - 06/2010
3	Insulin Resistance 07/2022 - 04/2021
3	Hypertension (High Blood Pressure) 12/2021 - 01/2018
3	Atrophy 09/2021 - 11/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
3	Malaria 06/2005 - 08/2002
2	Body Weight (Weight, Body) 07/2022 - 04/2021
2	Obesity 07/2022 - 01/2016
2	Neuroinflammatory Diseases 01/2022 - 09/2015
2	Colitis 01/2022 - 01/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 01/2021
2	Dementia (Dementias) 04/2021 - 11/2016
2	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 11/2016
2	Hyperhomocysteinemia 04/2021 - 12/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021 - 01/2015
2	Wounds and Injuries (Trauma) 01/2021 - 10/2018
2	Chronic Disease (Chronic Diseases) 01/2020 - 10/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019 - 01/2017
2	Cognitive Dysfunction 01/2018 - 11/2016
2	Atherosclerosis 12/2017 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 04/2016
2	Bone Resorption 11/2016 - 11/2016

Drug/Important Bio-Agent (IBA)

37	Peptides (Polypeptides)IBA 12/2021 - 01/2002
30	VaccinesIBA 01/2022 - 08/2002
17	AntigensIBA 07/2019 - 05/2002
16	CytokinesIBA 04/2021 - 02/2003
15	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2003
12	LigandsIBA 09/2015 - 01/2002
10	EpitopesIBA 03/2022 - 01/2002
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
6	Mucin-1 (CA 15-3 Antigen)IBA 01/2022 - 01/2006
6	MannansIBA 12/2021 - 03/2007
6	Vitamin B Complex (B Vitamins)IBA 04/2021 - 11/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
5	Cancer VaccinesIBA 07/2019 - 11/2006
5	Myelin Basic ProteinIBA 09/2015 - 01/2002
4	DNA VaccinesIBA 12/2021 - 03/2007
4	AntibodiesIBA 12/2021 - 02/2003
3	Interleukin-10 (Interleukin 10)IBA 02/2020 - 03/2005
3	OsteocalcinIBA 11/2019 - 11/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 01/2005
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2017 - 09/2008
3	Amino Acids FDA Link 01/2017 - 11/2011
3	Glycoproteins (Glycoprotein)IBA 12/2012 - 01/2006
2	Oxygen (Dioxygen)IBA 01/2022 - 06/2018
2	Vitamin D FDA LinkGeneric 10/2021 - 04/2019
2	phytobacteriomycin (PBM)IBA 08/2021 - 01/2021
2	CarnosineIBA 04/2021 - 03/2021
2	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 01/2021
2	HomocysteineIBA 04/2021 - 11/2016
2	PolyphenolsIBA 02/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2021
2	Angiotensin IIIBA 01/2021 - 01/2021
2	Cyclic PeptidesIBA 01/2021 - 03/2005
2	CarbohydratesIBA 01/2021 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 02/2020 - 01/2017
2	Interleukin-4 (Interleukin 4)IBA 02/2020 - 09/2004
2	EnzymesIBA 04/2019 - 11/2012
2	CalciumIBA 04/2019 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 06/2018 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 11/2017
2	alamandineIBA 12/2017 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 12/2015
2	Monoclonal AntibodiesIBA 01/2017 - 02/2003
2	Myelin ProteinsIBA 01/2017 - 01/2005
2	deoxypyridinolineIBA 11/2016 - 11/2016
2	Hormones (Hormone)IBA 11/2016 - 11/2010
2	pyridinolineIBA 11/2016 - 11/2016
2	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 09/2015 - 02/2015
2	AutoantigensIBA 07/2014 - 01/2002
2	Cell Surface ReceptorsIBA 07/2014 - 01/2013
2	penetratinIBA 11/2011 - 04/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2010 - 11/2006
2	Neoplasm Antigens (Tumor Antigens)IBA 02/2006 - 01/2005
1	1H-tetrazole (tetrazole)IBA 11/2022
1	Arginine (L-Arginine)FDA Link 11/2022
1	Angiotensin II Type 1 Receptor BlockersIBA 11/2022
1	FurinIBA 11/2022
1	TetrazolesIBA 11/2022
1	diphenyl (biphenyl)IBA 11/2022
1	gastric inhibitory polypeptide receptorIBA 07/2022

Therapy/Procedure

28	Immunotherapy 12/2021 - 02/2003
20	Therapeutics 11/2022 - 02/2003
3	Low-Level Light Therapy (LLLT) 08/2021 - 01/2020
2	Immunomodulation 05/2020 - 02/2015